EMA Stands Firm On Estradiol Cream Safety Measure After Doubts Over Impartiality
A warning must be placed on product packaging
After a 14-year-old legal dispute, the European Medicines Agency has now repeated its safety review of high-strength estradiol creams for treating vaginal atrophy and says it stands by its original recommendation to place a limit on how long patients should use these products.
